BRF1 mutations alter RNA polymerase III-dependent transcription and cause neurodevelopmental anomalies.
Fiche du document
2015
- doi: 10.1101/gr.176925.114
- issn: 1088-9051
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1101/gr.176925.114
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/25561519
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1549-5469
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_BFE1C03EAD4D1
info:eu-repo/semantics/openAccess , CC BY-NC 4.0 , https://creativecommons.org/licenses/by-nc/4.0/
Sujets proches
Speech--Transcription Language and languages--Transcription Transcribing TranscribingCiter ce document
G. Borck et al., « BRF1 mutations alter RNA polymerase III-dependent transcription and cause neurodevelopmental anomalies. », Serveur académique Lausannois, ID : 10.1101/gr.176925.114
Métriques
Partage / Export
Résumé
RNA polymerase III (Pol III) synthesizes tRNAs and other small noncoding RNAs to regulate protein synthesis. Dysregulation of Pol III transcription has been linked to cancer, and germline mutations in genes encoding Pol III subunits or tRNA processing factors cause neurogenetic disorders in humans, such as hypomyelinating leukodystrophies and pontocerebellar hypoplasia. Here we describe an autosomal recessive disorder characterized by cerebellar hypoplasia and intellectual disability, as well as facial dysmorphic features, short stature, microcephaly, and dental anomalies. Whole-exome sequencing revealed biallelic missense alterations of BRF1 in three families. In support of the pathogenic potential of the discovered alleles, suppression or CRISPR-mediated deletion of brf1 in zebrafish embryos recapitulated key neurodevelopmental phenotypes; in vivo complementation showed all four candidate mutations to be pathogenic in an apparent isoform-specific context. BRF1 associates with BDP1 and TBP to form the transcription factor IIIB (TFIIIB), which recruits Pol III to target genes. We show that disease-causing mutations reduce Brf1 occupancy at tRNA target genes in Saccharomyces cerevisiae and impair cell growth. Moreover, BRF1 mutations reduce Pol III-related transcription activity in vitro. Taken together, our data show that BRF1 mutations that reduce protein activity cause neurodevelopmental anomalies, suggesting that BRF1-mediated Pol III transcription is required for normal cerebellar and cognitive development.